• Using imlifidase to elucidate the characteristics and importance of anti-GBM antibodies produced after start of treatmentTyrberg, Linnea; Andersson, Fanny; Uhlin, Nils Fredrik Arne; Hellmark, Thomas; Segelmark, MartenNephrology Dialysis Transplantation2024 / p. 45-54 https://doi.org/10.1093/ndt/gfad132 https://www.scopus.com/sourceid/20021 https://www.scopus.com/pages/publications/85180568690 https://jcr.clarivate.com/jcr-jp/journal-profile?journal=NEPHROL%20DIAL%20TRANSPL&year=2024 https://www.webofscience.com/wos/woscc/full-record/WOS:001032410200001